Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 2/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.46 |
| ▸ | IGLV6-57 | P01721 | 2/20 | 0.36 |
| ▸ | NAMPT | P43490 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6637260 | 0.92 | CTRB1 (0.46) | CTRB1ELANENPC1RAB9AL3MBTL1 | |
| SCHEMBL6638087 | 0.88 | CYP3A4 (0.47) | CTRB1ELANENAMPTCYP3A4 | |
| SCHEMBL6636983 | 0.87 | CTRB1 (0.46) | CTRB1ELANEIGLV6-57NAMPTCYP3A4 | |
| SCHEMBL6639583 | 0.87 | CTRB1 (0.49) | CTRB1ELANEIGLV6-57NAMPTCYP3A4 | |
| SCHEMBL6640954 | 0.87 | CTRB1 (0.51) | CTRB1ELANEIGLV6-57NAMPTCYP3A4 | |
| SCHEMBL6641432 | 0.87 | CTRB1 (0.48) | CTRB1ELANENPC1RAB9A | |
| SCHEMBL6639093 | 0.86 | CTRB1 (0.51) | CTRB1ELANEIGLV6-57NAMPTCYP3A4 | |
| SCHEMBL6638443 | 0.85 | CTRB1 (0.47) | CTRB1ELANEIGLV6-57NAMPTCYP3A4 | |
| SCHEMBL6639087 | 0.85 | CTRB1 (0.49) | CTRB1ELANEIGLV6-57NAMPTCYP3A4 | |
| SCHEMBL6641671 | 0.84 | ELANE (0.52) | CTRB1ELANEIGLV6-57NAMPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1403269-A1 | REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE | Asahi Kasei Pharma Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |